We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Vodafone
VOD
$36.5B
| $1K | ﹤0.01% |
55
+7
| +15% | +$131 |
|
|
BBL
852
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1K | ﹤0.01% |
23
-23
| -50% | -$1.41K |
|
853
Advance Auto Parts
AAP
$3.51B
| – | – |
-3,105
| Closed | -$470K |
|
854
ADC Therapeutics
ADCT
$151M
| – | – |
-8
| Closed | – |
|
|
ADVM
855
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-29,849
| Closed | -$3.11M |
|
856
Afya
AFYA
$1.31B
| – | – |
-60,000
| Closed | -$1.46M |
|
857
Agios Pharmaceuticals
AGIO
$2.25B
| – | – |
-241,987
| Closed | -$10.1M |
|
858
Alector
ALEC
$169M
| – | – |
-154,783
| Closed | -$2.25M |
|
859
Autoliv
ALV
$8.66B
| – | – |
-45,469
| Closed | -$4.02M |
|
860
AngioDynamics
ANGO
$571M
| – | – |
-102,687
| Closed | -$1.51M |
|
861
Artivion
AORT
$1.28B
| – | – |
-29,166
| Closed | -$661K |
|
862
Aprea Therapeutics
APRE
$7.92M
| – | – |
-18,116
| Closed | -$1.71M |
|
863
Accuray
ARAY
$27.2M
| – | – |
-71,884
| Closed | -$288K |
|
864
Arcturus Therapeutics
ARCT
$164M
| – | – |
-53,633
| Closed | -$2.23M |
|
865
Array Technologies
ARRY
$840M
| – | – |
-320,484
| Closed | -$13.3M |
|
866
ASE Group
ASX
$78.6B
| – | – |
-33,156
| Closed | -$186K |
|
867
Axalta
AXTA
$7.14B
| – | – |
-56,334
| Closed | -$1.54M |
|
868
Boeing
BA
$168B
| – | – |
-5,179
| Closed | -$1.06M |
|
|
BLUE
869
DELISTED
bluebird bio
BLUE
| – | – |
-32,663
| Closed | -$17.6M |
|
870
B2Gold
BTG
$5.18B
| – | – |
-26,281
| Closed | -$141K |
|
871
Beyond Meat
BYND
$288M
| – | – |
-12,209
| Closed | -$1.47M |
|
|
BZUN
872
Baozun
BZUN
$165M
| – | – |
-10,000
| Closed | -$330K |
|
873
Cameco
CCJ
$38.8B
| – | – |
-18,346
| Closed | -$236K |
|
874
Coherus Oncology
CHRS
$227M
| – | – |
-680,812
| Closed | -$11.4M |
|
875
Grupo Cibest SA
CIB
$20.8B
| – | – |
-9,130
| Closed | -$352K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.